Kang HK, Park JS, Choi BH, Nguyen Pham TN, Zhu XW, Kim SK, Cho D, Nam JH, Kim YJ, Rhee JH, Kim, Lee JJ. Down-regulation of cellular VEGF levels induces differentiation of leukemic cells to functional leukemic-dendritic cells in acute myeloid leukemia. Leuk Lymphoma. 2006 Oct;47(10):2224-33
Choi BH, Kang HK, Park JS, Kim SK, Nguyen Pham TN, Zhu XW, Cho D, Nam JH, Chung IJ, Kim YJ, Rhee JH, Kim HJ, Lee JJ. Optimization of the concentration of autologous serum for generation of leukemic dendritic cells from acute myeloid leukemic cells for clinical immunotherapy. J Clin Apher. 2006 Dec;21(4):233-40
Cho D, Shin SW, Park JS, Kang HK, Kim SK, Nguyen Pham TN, Zhu XW, Shin MG, Suh SP, Ryang DW, Nam JH, Kim YJ, Lee JJ. Selective expansion of Natural killer cells from peripheral blood mononuclear cells by K562 cell line and IL-2. Korean J Hematol 2006 March: 41(1):8-15
Park MS, Park JS, Kang HK, Kim SK, Won JH, Choi BH, Shin SW, Zhu XW, Jin CJ , Nguyen Pham TN, Cho D, Nam JH, Kim YK, Yang DH, Chung IJ, Kim HJ, Lee JJ. Induction of myeloma cell line-specific cytotoxic T lymphocyte using monocyte-derived dendritic cell pulsed with myeloma cell line lysates. Korean J Hematol 2006 Sep: 41(3):186-193
Lee JJ, Park MS, Park JS, Kang HK, Kim SK, Nguyen Pham TN, Zhu XW, Cho D, Nam JH, Kim YJ, Rhee JH, Chung IJ, Kim HJ. Induction of leukemic-cell-specific cytotoxic T lymphocytes by autologous monocyte-derived dendritic cells presenting leukemic cell antigens. J Chin Apher. 2006 Mar 28: J Clin Apher. 2006 Oct;21(3):188-94
Lee JJ, Park MS, Park JS, Kang HK, Kim SK, Choi BH, Nguyen Pham TN, Cho D, Nam JH, Kim YJ, Rhee JH, Yang DH, Kim YK, Chung IJ, Kim HJ. Induction of multiple myeloma-specific cytotoxic T lymphocyte stimulation by dendritic cell pulsing with purified and optimized myeloma cell lysates. Leuk Lymphoma. 2007 Oct;48(10):2022-31
Nguyen Pham TN, Choi BH, Kang HK, Jin CC, Minh NH, Kim SK, Nam JH, Yang DH, Kim YK, Kim HJ, Chung IJ, Lee JJ. Optimization and Limitation of Calcium Ionophore to Generate DCs from Acute Myeloid Leukemic Cells. Cancer Res Treat. 2007 Dec;39(4):175-80
Kim SK, Nguyen Pham TN, Nguyen Hoang TM, Kang HK, Jin CJ, Nam JH, Chung SY, Choi SJ, Yang DH, Kim YK, Chung IJ, Kim HJ, Lee JJ. Induction of myeloma-specific cytotoxic T lymphocytes ex vivo by CD40-activated B cells loaded with myeloma tumor antigens. (Sang-Ki Kim and Thanh-Nhan Nguyen Pham equally contributed to this work). Ann Hematol. 2009 Nov;88(11):1113-23.
Jin CJ, Hong CY, Chung SY, Park JS, Takei M, Nguyen Pham TN, Choi SJN, Kim SK, Nam JH, Yang DH, Kim YK, Chung IJ, Kim HJ, Lee JJ. All-trans retinoic acid inhibits the differentiation, maturation, and function of human monocyte-derived dendritic cells. Leuk Res. 2010 Apr;34(4):513-20.
Yang DH, Kim MH, Hong CY, Lee YK, Jin CJ, Nguyen-Pham TN, Ahn JS, Bae WK, Kim YK, Chung IJ, Kim HJ, Kalinski P, Lee JJ. Alpha-type 1-polarized dendritic cells loaded with apoptotic allogeneic myeloma cell line induce strong CTL responses against autologous myeloma cells. Ann Hematol. 2010 Aug;89(8):795-801. Epub 2010 Mar 18.
Jung TY, Nguyen-Pham TN, Umeyama A, Shoji N, Hashimoto T, Lee JJ, Takei M. Ursolic acid isolated from Uncaria rhynchophylla activates human dendritic cells via TLR2 and/or TLR4 and induces the production of IFN-gamma by CD4+ naïve T cells. Eur J Pharmacol. 2010 Sep 25;643(2-3):297-303.
Nguyen-Pham TN, Hong CY, Min JJ, Rhee JH, Nguyen TA, Park BC, Yang DH, Park YK, Kim HR, Chung IJ, Kim HJ, Lee JJ. Enhancement of antitumor effect using dendritic cells activated with natural killer cells in the presence of Toll-like receptor agonist. Exp Mol Med. 2010 Jun 30;42(6):407-19.
Nguyen-Pham TN, Im MS, Nguyen TA, Lee YK, Jin CJ, Lee HJ, Hong CY, Ahn JS, Yang DH, Kim YK, Chung IJ, Park BC, Kim HJ, Lee JJ. Type I and II interferons enhance dendritic cell maturation and migration capacity by regulating CD38 and CD74 that have synergistic effects with TLR agonists. Cell Mol Immunol. 8, 341-347 (July 2011)
Kim KS, Nguyen-Pham TN, Jin CJ, Umeyama A, Shoji N, Hashimoto T, Lee JJ, Takei M. Uncarinic Acid C Isolated from Uncaria rhynchophylla Induces Differentiation of Th1-Promoting Dendritic Cells Through TLR4 Signaling. Biomarker Insights 2011:6 27-38
Yang DH, Kim MH, Lee YK, Hong CY, Lee HJ, Nguyen-Pham TN, Bae SY, Ahn JS, Kim YK, Chung IJ, Kim HJ, Kalinski P, Lee JJ. Successful cross-presentation of allogeneic myeloma cells by autologous alpha-type 1-polarized dendritic cells as an effective tumor antigen in myeloma patients with matched monoclonal immunoglobulins. Ann Hematol. 2011 Dec;90(12):1419-26. Epub 2011 Apr 5.
Park MH, Yang DH, Kim MH, Jang JH, Jang YY, Lee YK, Jin CJ, Nguyen-Pham TN, Nguyen TA, Lim MS, Lee HJ, Hong CY, Yoon JH, Lee JJ. Alpha-Type 1 Polarized Dendritic Cells Loaded with Apoptotic Allogeneic Breast Cancer Cells Can Induce Potent Cytotoxic T Lymphocytes against Breast Cancer. Cancer Res Treat. 2011 Mar;43(1):56-66
Nguyen-Pham TN, Im CM, Nguyen TA, Lim MS, Hong CY, Kim MH, Lee HJ, Lee YK, Cho D, Ahn JS, Yang DH, Kim YK, Chung IJ, Kim HJ, Lee JJ. Induction of myeloma-specific cytotoxic T lymphocytes responses by natural killer cells stimulated-dendritic cells in patients with multiple myeloma. Leuk Res. 2011 May 23;35:1241-1247
Nguyen-Pham TN, Yang DH, Nguyen TA, Lim MS, Hong CY, Kim MH, Lee HJ, Lee YK, Cho D, Bae SY, Ahn JS, Kim YK, Chung IJ, Kim HJ, Lee JJ. Optimal culture conditions for the generation of natural killer cell-induced dendritic cells for cancer immunotherapy. Cell Mol Immunol. 2012 Jan;9(1):45-53.
Lee HJ, Hong CY, Kim MH, Lee YK, Nguyen-Pham TN, Park BC, Yang DH, Chung IJ, Kim HJ, Lee JJ. In vitro induction of anterior gradient-2-specific cytotoxic T lymphocytes by dendritic cells transduced with recombinant adenoviruses as a potential target for colorectal cancer. Exp Mol Med. 2011 Nov 16. [Epub ahead of print]
Ju Lee H, Yi Hong C, Jin CJ, Kim MH, Lee YK, Nguyen-Pham TN, Lee H, Chul Park B, Chung IJ, Kim HJ, Lee JJ. Identification of novel HLA-A*0201-restricted epitopes from anterior gradient-2 as a tumor-associated antigen against colorectal cancer. Cell Mol Immunol. 2012 Jan 9. doi: 10.1038/cmi.2011.52. [Epub ahead of print]
Nguyen-Pham TN, Lee YK, Kim HJ, Lee JJ. Immunotherapy using Dendritic Cells against Multiple Myeloma: How to improve?. Clin Dev Immunol. 2012;2012:397648. Epub 2012 Mar 15.
Nguyen-Pham TN, Lee YK, Lee HJ, Kim MH, Yang DH, Kim HJ, Lee JJ. Cellular immunotherapy using dendritic cells against multiple myeloma. Korean J Hematol. 2012 Mar;47(1):17-27. Epub 2012 Mar 28
Hwang EC, Lim MS, Im CM, Kwon DD, Lee HJ, Nguyen-Pham TN, Lee YK, Lee JJ. Generation of potent cytotoxic T lymphocytes against castration-resistant prostate cancer cells by dendritic cells loaded with dying allogeneic prostate cancer cells. Scand J Immunol. 2013 Feb;77(2):117-24. doi: 10.1111/sji.12007.
Tran HT, Kim HN, Lee IK, Nguyen-Pham TN, Ahn JS, Kim YK, Lee JJ, Park KS, Kook H, Kim HJ. Improved Therapeutic Effect against Leukemia by a Combination of the Histone Methyltransferase Inhibitor Chaetocin and the Histone Deacetylase Inhibitor Trichostatin A. J Korean Med Sci. 2013 Feb;28(2):237-46. Epub 2013 Jan 29.
Jung SH, Lee YK, Lee HJ, Choi NR, Vo MC, Hoang MD, Lim MS, Nguyen-Pham TN, Kim HJ, Lee JJ. Dendritic cells loaded with myeloma cells pretreated with a combination of JSI-124 and bortezomib generate potent myeloma-specific cytotoxic T lymphocytes in vitro. Exp Hematol. 2014 Jan 7. pii: S0301-472X(14)00004-6. doi: 10.1016/j.exphem.2013.12.008. [Epub ahead of print].
Hoang MD, Jung SH, Lee HJ, Lee YK, Nguyen-Pham TN, Choi NR, Vo MC, Lee SS, Ahn JS, Yang DH, Kim YK, Kim HJ, Lee JJ. Dendritic Cell-Based Cancer Immunotherapy against Multiple Myeloma: From Bench to Clinic.. Chonnam Med J. 2015 Apr;51(1):1-7. doi: 10.4068/cmj.2015.51.1.1. Epub 2015 Apr 14. Review
Hoang MD, Lee HJ, Lee HJ, Jung SH, Choi NR, Vo MC, Nguyen-Pham TN, Kim HJ, Park IK, Lee JJ. Branched Polyethylenimine-Superparamagnetic Iron Oxide Nanoparticles (bPEI-SPIONs) Improve the Immunogenicity of Tumor Antigens and Enhance Th1 Polarization of Dendritic Cells.. J Immunol Res. 2015;2015:706379. doi: 10.1155/2015/706379. Epub 2015 Jun 28.
Nguyen-Pham TN, Jung SH, Vo MC, Thanh-Tran HT, Lee YK, Lee HJ, Choi NR, Hoang MD, Kim HJ, Lee JJ. Lenalidomide Synergistically Enhances the Effect of Dendritic Cell Vaccination in a Model of Murine Multiple Myeloma. J Immunother. 2015 Oct;38(8):330-9. doi: 10.1097/CJI.0000000000000097
Vo MC, Anh-NguyenThi T, Lee HJ, Nguyen-Pham TN, Jaya Lakshmi T, Jung SH, Kim HJ, Lee JJ. Lenalidomide enhances the function of dendritic cells generated from patients with multiple myeloma. Exp Hematol. 2017 Feb;46:48-55. doi: 10.1016/j.exphem.2016.11.004.
Vo MC, Nguyen-Pham TN, Lee HJ, Jung SH, Choi NR, Hoang MD, Kim HJ, Lee JJ. Chaetocin enhances dendritic cell function via the induction of heat shock protein and cancer testis antigens in myeloma cells. Oncotarget. 2017 Jul 11;8(28):46047-46056. doi: 10.18632/oncotarget.17517.
Vo MC, Nguyen-Pham TN, Lee HJ, Jaya Lakshmi T, Yang S, Jung SH, Kim HJ, Lee JJ. Combination therapy with dendritic cells and lenalidomide is an effective approach to enhance antitumor immunity in a mouse colon cancer model. Oncotarget. 2017 Apr 18;8(16):27252-27262. doi: 10.18632/oncotarget.15917.
